Dr. Michael P. Weaver, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 97 Troutwood Dr, New Hartford, CT 06057 Phone: 860-738-8216 |
News Archive
A small but significant percentage of college athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation of the heart muscle, that can only be seen on cardiac MRI, according to a study being presented today at the annual meeting of the Radiological Society of North America.
SignaBlok, Inc., a Massachusetts-based biopharmaceutical company, today announced the successful in vivo proof of concept data that demonstrate that the company's novel mechanism-based, first-in-class peptide inhibitor of TREM-1 effectively suppresses cancer progression in mouse models of lung cancer and dramatically improves survival in septic mice.
Bruker announced the launch today of the ContourGT-I 3D Optical Microscope to enhance R&D productivity and maximize manufacturing throughput for industrial applications. The ContourGT-I has been optimized to accelerate and simplify measurement setup and feature-tracking and is the world's first bench top profiling system to incorporate Bruker's proprietary tip/tilt head design, along with fully automated functionality, including turret, lenses, and illumination.
The California Environmental Protection Agency signaled intent to add bisphenol A (BPA) to the state's list of chemicals known to cause cancer or birth defects, adding to evidence the chemical should be banned from food and beverage containers.
Transgender and gender-diverse adults are three to six times more likely as cisgender adults (individuals whose gender identity corresponds to their sex assigned at birth) to be diagnosed as autistic, according to a new study by scientists at the University of Cambridge's Autism Research Centre.
› Verified 1 days ago